Vall d'Hebron Talks by VHIR 'Unveiling new targets for melanoma treatment involved in the prevention of BRAFV600E-induced cell arrest'

 Vall d'Hebron Talks by VHIR
  Sala d’actes de la planta baixa de l'edifici Collserola del VHIR — See in map
06/03/2024 -- From 12:00h to 13:00h
Organize :
Vall d'Hebron Institut de Recerca (VHIR)
Modality: Presencial
Share it:

Speaker: Kimberley McGrail, is currently a Postdoctoral Researcher at the Biomedical Research in Melanoma Group (VHIR). She studied Biology at the University of Málaga and then she moved to Barcelona to do a master in Advanced Genetics at the University of Barcelona (UAB). She did her PhD in the group of Biomedical Research in Melanoma and nowadays she is working in the lab as a postdoctoral researcher.

BRAFV600E-induced cell growth arrest in melanocytic nevus is on debate where only one third of melanomas arise directly from nevi. We showed that simultaneous neonatal oncogene (BRAFV600E) activation and UVB irradiation prevent BRAFV600E-induced growth arrest in melanocytes, allowing melanoma development. A meta-analysis of gene expression profiles of melanocytes isolated from different mouse models and numerous studies revealed multiple common genes and processes involved in preventing BRAFV600E-induced growth arrest. In humans, many of these genes are associated with poor survival and are upregulated during melanoma progression and in many RAS pathway activation-driven tumors. Single-cell profiling confirmed that BRAFV600E and the identified genes cooperate in melanocyte transformation, including the acquisition of multidrug resistance features. Depletion of these genes in vitro and in vivo revealed the utility of the encoded proteins as therapeutic targets. These results support the existence of BRAFV600E-mutated melanomas unassociated with nevus progression and identify targets for melanoma treatment.

Host: Dr. Juan Ángel Recio,  Head of group Biomedical Research in Melanoma  (VHIR)

Related activities

Curs SedUCI 2024. Per una estratègia protectora. De la teoria a la pràctica

06/03/2024 - 08:30
Professionals involucrats en la cura del pacient crític i amb interès a oferir el millor maneig de la sedació, analgèsia i delirium.
More information

III Jornada Parkinson Vall d’Hebron '40 anys tractant i investigant la malaltia de Parkinson'

06/06/2024 - 15:30
More information

Escuela de Verano de genética asistencial. Aplicación práctica de la genética en contexto clínico

06/10/2024 - 16:00
More information

3er Curs Patologia Hipotàlem Hipofisiària

06/11/2024 - 08:15
Professionals sanitaris
More information

Subscribe to our newsletters and be a part of Vall d'Hebron Campus

Select the newsletter you want to receive:

By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to, clearly stating the subject as "Exercising of Data Protection Rights".
Operated by: Vall d’Hebron University Hospital Foundation – Research Institute.
Purpose: Manage the user’s contact information.
Legitimisation: Express acceptance of the privacy policy.
Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use.
Source: The interested party themselves.